Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ardelyx Inc (NQ: ARDX )

3.350 +0.130 (+4.04%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 7, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,947,862
Open 3.250
Bid (Size) 3.310 (7)
Ask (Size) 3.320 (7)
Prev. Close 3.220
Today's Range 3.120 - 3.350
52wk Range 0.4902 - 3.430
Shares Outstanding 103,119,010
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
7 A-Rated Stocks to Buy for February 2023
Now's the time to pounce on these seven high-quality stocks to buy; each one earns an A rating in Portfolio Grader. 
Via InvestorPlace
7 A-Rated Stocks to Buy for Less Than $25
These seven stocks to buy for less than $25 per share are strong opportunities in today's resilient yet uncertain market. 
Via InvestorPlace

Performance

YTD
+25.00%
+25.00%
1 Month
+23.16%
+23.16%
3 Month
+157.69%
+157.69%
6 Month
+280.94%
+280.94%
1 Year
+322.93%
+322.93%

More News

Read More
PPG Industries, Netflix, Ally Financial And Other Big Stocks Moving Higher On Friday
Via Benzinga
Why Ardelyx Shares Are Falling
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
5 Under-the-Radar Penny Stocks With 100% Upside Potential
Via InvestorPlace
Bulls In A Bear Market: These 10 Stocks Clocked Gains In Excess Of 100% In 2022
Via Benzinga
Ardelyx To Rally 160%? Here Are 10 Other Price Target Changes For Friday
Via Benzinga
Dow Surges 250 Points; Jobless Claims Rise To 225,000
Via Benzinga
The 3 Biggest Opportunities for Penny Stock Investors in 2023
Via InvestorPlace
Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Melco, Ardelyx And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
Via Benzinga
FDA Needs More Time For Ardelyx's Appeal To Rejection Of Kidney Disease Candidate
Via Benzinga
Why Innate Pharma Shares Are Trading Higher By 24%; Here Are 34 Stocks Moving Premarket
Via Benzinga
The 7 Hottest Biotech Stocks to Own in 2023 and Beyond
Via InvestorPlace
How Is The Market Feeling About Ardelyx?
Via Benzinga
Planned Government Move To Expand Access To Drugs For End-Stage Renal Disease Patients Could Shine The Spotlight On Unicycive
Via Benzinga
EXCLUSIVE: Top 10 Searched Tickers On Benzinga Pro In November 2022: Where Do Tesla, Apple, A Donald Trump-Linked SPAC Rank?
Via Benzinga
3 Biotech Stocks Smart Investors Should Be Buying Up Now
Via InvestorPlace
Dollar Tree, Dycom Industries, Chico's FAS And Other Big Losers From Tuesday
Via Benzinga
Is Ardelyx is A Buy After Slip in Early 2022
Via MarketBeat
Exposures Product Safety
CapitalGainsReport Sector Spotlight: Healthcare Penny Stocks On The Move (ARDX, WHSI, BNGO)
Via AB Newswire
Why InMed Pharmaceuticals Shares Tumbled 28%; Here Are 67 Biggest Movers From Friday
Via Benzinga
Foot Locker, Ross Stores, Palo Alto Networks, And Other Big Gainers From Friday
Via Benzinga
2 Biotech Stocks That Can Rocket Higher in 2023, According to Wall Street
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.